Aptose Biosciences Inc. (TSX: APS)

Aptose Biosciences Ratios and Metrics

Market cap in millions CAD. Fiscal year is January - December.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	20	27	72	154	497	559
Market Cap Growth	-56.49%	-63.04%	-53.23%	-69.01%	-11.20%	469.60%
Enterprise Value	8	4	-4	35	321	522
Last Close Price	0.89	3.35	11.70	25.95	83.85	110.25
PE Ratio	-	-0.33	-1.27	-1.86	-6.50	-10.82
PB Ratio	75.41	-6.94	1.41	1.64	3.28	4.59
P/FCF Ratio	-0.58	-0.45	-1.64	-2.80	-11.48	-19.91
P/OCF Ratio	-0.58	-0.45	-1.65	-2.81	-11.50	-20.01
EV/EBITDA Ratio	-0.37	-0.06	0.06	-0.42	-4.54	-15.06
EV/EBIT Ratio	-0.37	-0.06	0.06	-0.42	-4.52	-14.97
EV/FCF Ratio	-0.13	-0.07	0.08	-0.63	-7.43	-18.56
Debt / Equity Ratio	6.71	-0.35	0.03	0.01	0.01	0.02
Debt / FCF Ratio	-0.02	-0.02	-0.04	-0.01	-0.03	-0.07
Quick Ratio	0.77	0.61	3.82	9.68	17.97	17.62
Current Ratio	0.97	0.78	4.03	10.00	18.36	17.83
Return on Equity (ROE)	-361.05%	-293.96%	-74.70%	-67.67%	-51.91%	-48.66%
Return on Assets (ROA)	-115.15%	-102.23%	-39.87%	-39.18%	-30.74%	-28.61%
Return on Capital (ROIC)	-212.31%	-176.13%	-46.77%	-42.00%	-32.36%	-30.65%
Earnings Yield	-844.80%	-254.17%	-78.63%	-53.73%	-14.17%	-6.09%
FCF Yield	-312.27%	-221.47%	-60.81%	-35.77%	-8.71%	-5.02%
Buyback Yield / Dilution	-37.99%	-9.82%	-3.57%	-8.86%	-63.15%	-50.22%
Total Shareholder Return	-37.99%	-9.82%	-3.57%	-8.86%	-63.15%	-50.22%

Source: S&P Capital IQ. Standard template.